Why is Sun Pharma Advanced Research Company Ltd ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 428.32% and Operating profit at 144.13%
2
Positive results in Jun 26
- PAT(9M) At Rs 1,672.50 cr has Grown at 974.97%
- NET SALES(9M) Higher at Rs 1,901.59 cr
3
With ROCE of 83.7, it has a Expensive valuation with a 3.6 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 38.05%, its profits have risen by 634.9% ; the PEG ratio of the company is 0
4
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 1.43% over the previous quarter and collectively hold 4% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
5
Market Beating Performance
- Even though the market (BSE500) has generated negative returns of -2.96% in the last 1 year, the stock has been able to generate 38.05% returns
How much should you hold?
- Overall Portfolio exposure to SPARC should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is SPARC for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
SPARC
36.86%
0.64
57.69%
Sensex
-9.4%
-0.70
13.49%
Quality key factors
Factor
Value
Sales Growth (5y)
428.32%
EBIT Growth (5y)
144.13%
EBIT to Interest (avg)
-59.80
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.42
Sales to Capital Employed (avg)
0.77
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.00%
ROCE (avg)
-178.66%
ROE (avg)
58.47%
Valuation Key Factors 
Factor
Value
P/E Ratio
4
Industry P/E
37
Price to Book Value
4.70
EV to EBIT
4.27
EV to EBITDA
4.24
EV to Capital Employed
3.61
EV to Sales
3.59
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
83.74%
ROE (Latest)
116.94%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
Technical Movement
28What is working for the Company
PAT(9M)
At Rs 1,672.50 cr has Grown at 974.97%
NET SALES(9M)
Higher at Rs 1,901.59 cr
-15What is not working for the Company
NET SALES(Q)
At Rs 39.92 cr has Fallen at -91.5% (vs previous 4Q average
PBT LESS OI(Q)
At Rs -44.33 cr has Fallen at -111.4% (vs previous 4Q average
PAT(Q)
At Rs -20.78 cr has Fallen at -105.3% (vs previous 4Q average
INTEREST(Latest six months)
At Rs 19.77 cr has Grown at 21.29%
Loading Valuation Snapshot...
Here's what is not working for SPARC
Net Sales - Quarterly
At Rs 39.92 cr has Fallen at -91.5% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 469.79 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -44.33 cr has Fallen at -111.4% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 388.61 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs -20.78 cr has Fallen at -105.3% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 391.39 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Interest - Latest six months
At Rs 19.77 cr has Grown at 21.29%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Non Operating Income - Quarterly
Highest at Rs 23.66 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income






